HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pocai, A. Articles by Rossetti, L. Search for Related Content PubMed PubMed Citation Articles by Pocai, A. Articles by Rossetti, L. Social Bookmarking                What's this?

Central Leptin Acutely Reverses Diet-Induced Hepatic Insulin Resistance

Departments of Medicine and Molecular Pharmacology, Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York

Voluntary overfeeding rapidly induces resistance to the effects of systemic insulin and leptin on liver glucose metabolism. To examine whether central administration of recombinant leptin can restore leptin and insulin action on liver glucose fluxes, we infused leptin in the third cerebral ventricle of conscious overfed rats during pancreatic-insulin clamp studies. The effect of leptin on the phosphorylation of the signal transducer and activator of transcription-3 in the arcuate nuclei of the hypothalamus was similar in animals fed a regular diet or a high-fat diet for 3 days. The infusion of leptin in the third cerebral ventricle markedly inhibited glucose production in rats fed a high-fat diet mainly by decreasing glycogenolysis. The inhibition of glycogenolysis was sufficient to normalize glucose production and was accompanied by leptin-induced decreases in the hepatic expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. Thus central administration of leptin rescues the hepatic insulin resistance induced by short-term hyperphagia.

Abbreviations: BBB, blood-brain barrier; CNS, central nervous system; G6Pase, glucose-6-phosphatase; PEP, phosphoenolpyruvate; STAT3, signal transducer and activator of transcription-3

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Guo, J. E. McMinn, T. Ludwig, Y.-H. Yu, G. Yang, L. Chen, D. Loh, C. Li, S. Chua Jr., and Y. Zhang Disruption of Peripheral Leptin Signaling in Mice Results in Hyperleptinemia without Associated Metabolic Abnormalities Endocrinology, August 1, 2007; 148(8): 3987 - 3997. [Abstract] [Full Text] [PDF]

				M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF]

				S. C. Woods, S. C. Benoit, and D. J. Clegg The Brain-Gut-Islet Connection Diabetes, December 1, 2006; 55(Supplement_2): S114 - S121. [Abstract] [Full Text] [PDF]

				R. S. Ahima, Y. Qi, N. S. Singhal, M. B. Jackson, and P. E. Scherer Brain Adipocytokine Action and Metabolic Regulation Diabetes, December 1, 2006; 55(Supplement_2): S145 - S154. [Abstract] [Full Text] [PDF]

				M. R. Jackman, R. E. Kramer, P. S. MacLean, and D. H. Bessesen Trafficking of dietary fat in obesity-prone and obesity-resistant rats Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1083 - E1091. [Abstract] [Full Text] [PDF]

				E. Prodi and S. Obici Minireview: The Brain as a Molecular Target for Diabetic Therapy Endocrinology, June 1, 2006; 147(6): 2664 - 2669. [Abstract] [Full Text] [PDF]